WhatsApp
backNews Article

Gland Pharma Allots 3,739 Equity Shares to Employees Under ESOP Scheme

Total issued share capital increases to Rs. 16,50,14,593 with shares issued at exercise prices of Rs. 773.30 and Rs. 1 per share on November 16, 2026

Gland Pharma Limited allotted 3,739 equity shares to 2 employees on November 16, 2026, under its Employee Stock Option Scheme 2025, increasing its total issued share capital to Rs. 16,50,14,593 comprising 165,014,593 equity shares of Rs.1 each. This issuance reflects ongoing employee stock benefits in compliance with SEBI regulations.

1 day ago|GLAND-0.55%
Gland Pharma Limited543245GLANDCorporate Action

Gland Pharma Limited

Corporate Action

Gland Pharma Limited allotted 3,739 equity shares to two employees upon exercise of stock options under its Employee Stock Option Scheme 2025, raising its total issued share capital to Rs. 16,50,14,593 as of November 16, 2026.

The equity shares allotted have a face value of Re. 1 each and are fully paid-up, issued pursuant to the exercise of employee stock options.

Of the shares allotted, 2,474 shares were issued at an exercise price of Rs. 773.30 each and 1,265 shares at Rs. 1 each, as defined under the company's ESOP 2025 scheme.

Following this allotment, the total number of equity shares stands at 165,014,593, maintaining parity with existing shares, with a total issued share capital of Rs. 16,50,14,593.

The shares were allotted on November 16, 2026, and no lock-in period applies to these newly issued shares.

The company's shares are listed on the BSE and the National Stock Exchange of India under the tickers 543245 and GLAND respectively.

Highlights

  • 3,739 equity shares allotted on November 16, 2026 to 2 employees under ESOP Scheme 2025.
  • Issued shares increased to 165,014,593 with total share capital of Rs. 16,50,14,593.
  • Exercise prices were Rs. 773.30 per share for 2,474 shares and Rs. 1 per share for 1,265 shares.
  • Shares issued rank pari passu with existing shares and have no lock-in period.
  • Shares listed on BSE (Scrip Code: 543245) and NSE (Symbol: GLAND).

Key Data Snapshot

Number of equity shares allotted3,739
Number of employees allotted shares2
Date of allotmentNovember 16, 2026
Total issued equity shares after allotment165,014,593
Total issued share capital after allotmentRs. 16,50,14,593
Face value per shareRe. 1
Exercise price for 2,474 sharesRs. 773.30 each
Exercise price for 1,265 sharesRs. 1 each
Listing exchangesBSE and NSE
ISIN numberINE068V01023

What happened

  • Gland Pharma allotted 3,739 fully paid equity shares to two employees exercising stock options.
  • Shares were issued under the Gland Pharma Employee Stock Option Scheme 2025.
  • The issuance took place on November 16, 2026, increasing the company's total issued share capital.

Key details

  • 2,474 shares were allotted at an exercise price of Rs. 773.30 per share and 1,265 shares at Rs. 1 per share.
  • The company’s issued share capital increased to Rs. 16,50,14,593, comprising 165,014,593 equity shares.
  • All allotted shares rank equally with existing equity shares and there is no lock-in period applicable.

Regulatory and governance context

  • The allotment complies with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021.
  • Company has filed required disclosures with both BSE and NSE as per regulatory obligations.

More News on Corporate Action

View all

Latest corporate announcements and market updates in Corporate Action.

View all news
Gland Pharma Allots 3,739 Equity Shares to Employees | Stockk News